SEC Form 4Coverage since Jun 3, 2026
$APGE insider trading
Over the last 12 months, Apogee Therapeutics insiders reported no purchases and 7 sales totaling $20.3M across SEC Form 4 filings. 100% of the activity was filed under pre-arranged 10b5-1 trading plans.
- Bought · 12m
- — 0 events
- Sold · 12m
- $20.3M 7 events
- Events · 12m
- 7 Form 4 filings, grouped
- Insiders · 12m
- 2 distinct reporters
- 10b5-1 share
- 100% pre-arranged plans
Side
Price · $APGE · 12Mvia TradingView
Top insiders · 12m
Dambkowski CarlChief Medical Officer4× · $5.4M
HENDERSON MICHAEL THOMASChief Executive Officer3× · $14.9M
All insider trades
7 events
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Aug 5, 2026 | Dambkowski CarlChief Medical Officer · O | ▼ Sale | 5,500 | $134.17 | $738K | -3.2% | plan |
| Jul 8, 2026 | HENDERSON MICHAEL THOMASChief Executive Officer · O·D | ▼ Sale | 20,000 | $133.63 | $2.7M | -2% | plan |
| Jul 1, 2026 | Dambkowski CarlChief Medical Officer · O | ▼ Sale | 5,500 | $132.74 | $730K | -3% | plan |
| Jun 22, 2026 | Dambkowski CarlChief Medical Officer · O | ▼ Sale | 26,400 | $132.6 | $3.5M | -12.8% | plan |
| Jun 22, 2026 | HENDERSON MICHAEL THOMASChief Executive Officer · O·D | ▼ Sale | 80,000 | $132.54 | $10.6M | -7.3% | plan |
| Jun 10, 2026 | HENDERSON MICHAEL THOMASChief Executive Officer · O·D | ▼ Sale | 20,000 | $83.38 | $1.7M | -1.8% | plan · 6 tranches |
| Jun 3, 2026 | Dambkowski CarlChief Medical Officer · O | ▼ Sale | 5,500 | $78.71 | $433K | -2.6% | plan |
About Form 4
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $APGE feed.